Recruiting Editorial Board Members for Sclerosis

In order to further enhance the international influence of the journal Sclerosis (ISSN: 2813-3064) and promote the academic exchange among researchers, we are currently recruiting prestigious scholars from around the world to join our Editorial Board.

Sclerosis is an international, peer-reviewed, open access journal on sclerosis and related diseases, published quarterly online by MDPI. The scope includes but is not limited to the following:

Amyotrophic lateral sclerosis;
Multiple sclerosis;
Primary lateral sclerosis;
Systemic sclerosis;
Atherosclerosis;
Focal segmental glomerulosclerosis;
Hippocampal sclerosis;
Lichen sclerosis;
Osteosclerosis;
Otosclerosis;
Primary sclerosing cholangitis;
Tuberous sclerosis.

The main responsibilities of Editorial Board Members are as follows:

Pre-screening and making decisions on new submissions related to their research interests;
Setting up at least one Special Issue during their term on a topic related to their research interests (or supervising Special Issues related to their research field);
Helping to attract suitable expert authors and inviting young scholars to join the Topical Advisory Panel;
Providing input or feedback regarding journal policies;
Helping to promote the journal among their peers or at conferences;
Attending Board meetings to suggest journal development strategies;
Reviewing manuscripts.

The benefits of becoming an Editorial Board Member include the following:

The opportunity to publish one paper, free of charge, per year in Sclerosis;
A certificate recognizing you as an Editorial Board Member of Sclerosis;
Expanded research network for new insights, collaborations, and opportunities for future research projects.

To apply for this position, recommend potential candidates, or request further information, please contact the Sclerosis Editorial Office at sclerosis@mdpi.com with the following two files attached:

A full academic CV;
A short cover letter that details your interest and enthusiasm for the position.

We look forward to hearing from you.

Sclerosis Editorial Office